Guo‐Kai Feng

1.3k total citations
42 papers, 707 citations indexed

About

Guo‐Kai Feng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Guo‐Kai Feng has authored 42 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Immunology. Recurrent topics in Guo‐Kai Feng's work include Cell Adhesion Molecules Research (13 papers), RNA Interference and Gene Delivery (8 papers) and Immunotherapy and Immune Responses (8 papers). Guo‐Kai Feng is often cited by papers focused on Cell Adhesion Molecules Research (13 papers), RNA Interference and Gene Delivery (8 papers) and Immunotherapy and Immune Responses (8 papers). Guo‐Kai Feng collaborates with scholars based in China, United States and Spain. Guo‐Kai Feng's co-authors include Mu‐Sheng Zeng, Qian Zhong, Yong Du, Man-Zhi Li, Dan Xiong, Wen-Lin Huang, Huamao Du, Hongbo Wang, Bo Zhao and Lindsey Hutt‐Fletcher and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Guo‐Kai Feng

41 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo‐Kai Feng China 16 355 241 162 138 78 42 707
Richard Karlsson Denmark 13 601 1.7× 160 0.7× 100 0.6× 110 0.8× 53 0.7× 21 936
Elizabeth K. Duperret United States 18 474 1.3× 435 1.8× 476 2.9× 143 1.0× 52 0.7× 25 1.1k
Elena Ortíz-Zapater United Kingdom 16 611 1.7× 197 0.8× 186 1.1× 118 0.9× 48 0.6× 32 1.0k
Emily N. Arner United States 8 260 0.7× 175 0.7× 213 1.3× 148 1.1× 38 0.5× 10 567
Yingjun Su China 10 341 1.0× 382 1.6× 252 1.6× 109 0.8× 54 0.7× 21 900
Shilpee Dutt India 21 902 2.5× 295 1.2× 269 1.7× 199 1.4× 83 1.1× 48 1.5k
Chunxiao Wu China 20 747 2.1× 135 0.6× 102 0.6× 247 1.8× 48 0.6× 54 1.1k
Praveena Thiagarajan United States 11 290 0.8× 241 1.0× 143 0.9× 112 0.8× 52 0.7× 17 597
Hyunbo Shim South Korea 17 439 1.2× 174 0.7× 173 1.1× 66 0.5× 34 0.4× 42 762
Shihe Hou United States 13 235 0.7× 212 0.9× 141 0.9× 131 0.9× 41 0.5× 25 624

Countries citing papers authored by Guo‐Kai Feng

Since Specialization
Citations

This map shows the geographic impact of Guo‐Kai Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Kai Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Kai Feng more than expected).

Fields of papers citing papers by Guo‐Kai Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Kai Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Kai Feng. The network helps show where Guo‐Kai Feng may publish in the future.

Co-authorship network of co-authors of Guo‐Kai Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Kai Feng. A scholar is included among the top collaborators of Guo‐Kai Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Kai Feng. Guo‐Kai Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Cong, Chu Xie, Dong‐Chun Hong, et al.. (2025). Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. Advanced Materials. 38(7). e07012–e07012. 1 indexed citations
2.
Chen, Liping, Haitian Fu, Wenjin Li, et al.. (2024). Development and preclinical evaluation of a cyclic PET tracer targeting integrin-α6 on colorectal cancer models. Bioorganic Chemistry. 153. 107892–107892.
3.
Li, Shuxin, Qiao-Li Wang, Guohui Wan, et al.. (2024). Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells. Biomedicine & Pharmacotherapy. 175. 116670–116670. 2 indexed citations
4.
Qiao, Weiguang, Shuxin Li, Linna Luo, et al.. (2024). Ce6-GFFY is a novel photosensitizer for colorectal cancer therapy. Genes & Diseases. 12(2). 101441–101441. 2 indexed citations
5.
Zhang, Wenbiao, et al.. (2023). Integrin α6 targeted cancer imaging and therapy. SHILAP Revista de lepidopterología. 4. 4–4. 3 indexed citations
6.
Li, Ruping, Xiaobin Zheng, Zhijian Li, et al.. (2023). EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2100–2113. 6 indexed citations
7.
Chen, Liping, et al.. (2023). Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer. Molecular Pharmaceutics. 20(8). 4277–4284. 5 indexed citations
8.
Bu, Guo‐Long, Xiang‐Wei Kong, Cong Sun, et al.. (2023). mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice. Advanced Science. 10(35). e2302116–e2302116. 21 indexed citations
9.
Lin, Yanzhu, You Wu, Jun Deng, et al.. (2022). Integrin α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations
10.
Li, Xinling, Zhijian Li, Xiaobin Zheng, et al.. (2022). Development of a Radiotracer for PET Imaging of the SNAP Tag. ACS Omega. 7(9). 7550–7555. 4 indexed citations
11.
Yang, Jie, Qiao-Li Wang, Guo‐Kai Feng, & Mu‐Sheng Zeng. (2020). Significance of Selective Protein Degradation in the Development of Novel Targeted Drugs and Its Implications in Cancer Therapy. Advanced Therapeutics. 3(6). 2 indexed citations
12.
Wang, Qian, Yan Mei, Wei Fan, et al.. (2020). The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer. Journal of Molecular Medicine. 98(10). 1457–1466. 34 indexed citations
13.
Feng, Guo‐Kai, Mengqing Zhang, Hongxia Wang, et al.. (2019). Identification of an Integrin α6‐Targeted Peptide for Nasopharyngeal Carcinoma‐Specific Nanotherapeutics. Advanced Therapeutics. 2(7). 24 indexed citations
14.
Shi, Huayun, V. Venkatesh, Guo‐Kai Feng, et al.. (2019). Photoactive platinum(iv) complex conjugated to a cancer-cell-targeting cyclic peptide. Dalton Transactions. 48(24). 8560–8564. 19 indexed citations
15.
Zhao, Jing, Jing Cai, Yan Mei, et al.. (2019). Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice. Molecular Imaging and Biology. 22(4). 864–872. 9 indexed citations
16.
Zhou, Chao, Zhijian Li, Mei Yan, et al.. (2019). Integrin α6-Targeted Positron Emission Tomography Imaging of Colorectal Cancer. ACS Omega. 4(13). 15560–15566. 16 indexed citations
17.
Han, Ping, Yu Zhang, Yongdong Liu, et al.. (2018). Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients. Journal of Molecular Medicine. 96(3-4). 265–279. 11 indexed citations
18.
Xiao, Wei, Jing Zhao, Man-Zhi Li, et al.. (2017). EDB Fibronectin-Specific SPECT Probe 99mTc-HYNIC-ZD2 for Breast Cancer Detection. ACS Omega. 2(6). 2459–2468. 15 indexed citations
19.
Feng, Guo‐Kai, Qian Zhong, Yun-Fei Xia, et al.. (2014). SPECT and Near-Infrared Fluorescence Imaging of Breast Cancer with a Neuropilin-1-Targeting Peptide. Journal of Controlled Release. 192. 236–242. 32 indexed citations
20.
Yang, Min, et al.. (2009). Anti-inflammatory effect of Sanshuibaihu decoction may be associated with nuclear factor-κB and p38 MAPKα in collagen-induced arthritis in rat. Journal of Ethnopharmacology. 127(2). 264–273. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Karlsson Breakdown of academic impact, for papers by Elizabeth K. Duperret Breakdown of academic impact, for papers by Elena Ortíz-Zapater Breakdown of academic impact, for papers by Emily N. Arner Breakdown of academic impact, for papers by Yingjun Su Breakdown of academic impact, for papers by Shilpee Dutt Breakdown of academic impact, for papers by Chunxiao Wu Breakdown of academic impact, for papers by Praveena Thiagarajan Breakdown of academic impact, for papers by Hyunbo Shim Breakdown of academic impact, for papers by Shihe Hou
Rankless by CCL
2026